CIK 0001682852 · Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813467528
- Phone
- 6177146500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,875,818
- in 4 filings, $33.9M under 10b5-1 plans
Net −$33,875,818. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-01 | Hussain Abbas Director | Sale 10b5-1 | −5,682 | $46.63 | $265K | 12,066 |
| 2026-04-30 | Horning Sandra Director | Option exercise | +16,233 | 18,585 | ||
| 2026-04-30 | Horning Sandra Director | Option exercise · Restricted Stock Units | −16,233 | 0 | ||
| 2026-04-30 | Rubenstein David M. Director | Option exercise | +8,116 | 9,643 | ||
| 2026-04-30 | Rubenstein David M. Director | Option exercise · Restricted Stock Units | −8,116 | 0 | ||
| 2026-04-30 | Hussain Abbas Director | Option exercise 10b5-1 | +16,233 | 17,748 | ||
| 2026-04-30 | Hussain Abbas Director | Option exercise · Restricted Stock Units 10b5-1 | −16,233 | 0 | ||
| 2026-04-30 | NABEL ELIZABETH G Director | Option exercise | +16,233 | 19,317 | ||
| 2026-04-30 | NABEL ELIZABETH G Director | Option exercise · Restricted Stock Units | −16,233 | 0 | ||
| 2026-04-30 | Nader Francois Director | Option exercise | +12,174 | 32,781 | ||
| 2026-04-30 | Nader Francois Director | Option exercise · Restricted Stock Units | −12,174 | 0 | ||
| 2026-04-30 | Tallett Elizabeth E Director | Option exercise | +4,058 | 4,761 | ||
| 2026-04-30 | Tallett Elizabeth E Director | Option exercise · Restricted Stock Units | −4,058 | 0 | ||
| 2026-04-02 | Mock James M Chief Financial Officer | Option exercise | +1,453 | 58,451 | ||
| 2026-04-02 | Mock James M Chief Financial Officer | Shares withheld for taxes | −703 | $50.03 | $35K | 57,748 |
| 2026-04-02 | Mock James M Chief Financial Officer | Option exercise · Restricted Stock Units | −1,453 | 2,906 | ||
| 2026-03-05 | Klinger Shannon Thyme Chief Legal Officer | Option exercise | +11,797 | 71,486 | ||
| 2026-03-05 | Klinger Shannon Thyme Chief Legal Officer | Shares withheld for taxes | −5,704 | $57.80 | $330K | 65,782 |
| 2026-03-05 | Klinger Shannon Thyme Chief Legal Officer | Option exercise · Restricted Stock Units | −11,797 | 129,774 | ||
| 2026-03-05 | Mock James M Chief Financial Officer | Option exercise | +11,797 | 62,702 |
Page 8 of 20 · 389 trades